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Coxiella burnetii is the etiological agent of Q fever. Currently, the Netherlands is facing the largest Q fever
epidemic ever, with almost 4,000 notified human cases. Although the presence of a hypervirulent strain is
hypothesized, epidemiological evidence, such as the animal reservoir(s) and genotype of the C. burnetii
strain(s) involved, is still lacking. We developed a single-nucleotide-polymorphism (SNP) genotyping assay
directly applicable to clinical samples. Ten discriminatory SNPs were carefully selected and detected by
real-time PCR. SNP genotyping appeared to be highly suitable for discrimination of C. burnetii strains and easy
to perform with clinical samples. With this new method, we show that the Dutch outbreak is caused by at least
5 different C. burnetii genotypes. SNP typing of 14 human samples from the outbreak revealed the presence of
3 dissimilar genotypes. Two genotypes were also present in livestock at 9 farms in the outbreak area. SNP
analyses of bulk milk from 5 other farms, commercial cow milk, and cow colostrum revealed 2 additional
genotypes that were not detected in humans. SNP genotyping data from clinical samples clearly demonstrate
that at least 5 different C. burnetii genotypes are involved in the Dutch outbreak.
Coxiella burnetii is a Gram-negative, obligate intracellular
bacterium and the causative agent of Q fever, a widespread
zoonotic infectious disease (2, 11). Human infections are often
associated with affected livestock, especially goats and sheep
(20). Its primary route of infection is through inhalation, with
less than 10 organisms being sufficient for human infection (2).
Because of its high infectivity and extreme resistance to heat,
UV radiation, disinfectants, and desiccation, C. burnetii is
listed as a category B biowarfare agent (15).
Sixty percent of patients exposed to C. burnetii seroconvert
asymptomatically, whereas 40% develop a disease known as
acute Q fever, which in general presents as a mild flu-like
disease. Some patients develop severe pneumonia and may
need hospitalization. The inoculum size has been associated
with the incubation time. Primary C. burnetii infection may
progress to chronic Q fever, presenting as endocarditis or vas-
cular disease in 78% and 9% of chronic Q fever patients,
respectively (19).
Currently, there is a Q fever epidemic of unprecedented
magnitude ongoing in the southern part of the Netherlands,
with almost 4,000 human cases being diagnosed since 2007.
Fifty-nine percent of notified human Q fever cases in 2009
lived within a 3-mile radius of an infected dairy goat or dairy
sheep farm, while only 12% (roughly 1 million people) of the
Dutch population resided within these zones (26). The most
affected province is Noord-Brabant, located in the south of the
Netherlands. Noord-Brabant covers 1,900 square miles and has
2.4 million inhabitants and about 6.4 million livestock (80,000
sheep, 135,000 goats, 660,000 cows, and 5.5 million pigs) (3). Q
fever was diagnosed at 74 dairy goat farms and 2 dairy sheep
farms, out of the total of 360 dairy goat farms and 40 dairy
sheep farms with more than 50 animals in the Netherlands
(26).
To date, several techniques for genotyping of C. burnetii
have been described: pulsed-field gel electrophoresis, plasmid
nested PCR, PCR-restriction fragment length polymorphism,
infrequent restriction site PCR (IRS-PCR), multispacer se-
quence typing, multiple-locus variable-number tandem-repeat
analysis (MLVA), and, recently, matrix-assisted laser desorp-
tion ionization–time-of-flight mass spectrometry (1, 5, 8, 9, 16,
22, 23, 29). Most of these techniques are limited in their sen-
sitivity and rely on enrichment of the bacterium by culture
before it can be genotyped. C. burnetii culture is mostly per-
formed by the use of tissue culture under biosafety level 3
conditions (18), for which the necessities are often not avail-
able in peripheral hospital laboratories. In addition, culturing
of C. burnetii is bound by strict government regulations due to
its infectious potential and status as a category B biowarfare
agent (15). A drawback of IRS-PCR and other gel-based sys-
tems is that these methods are not well-suited for interlabora-
tory standardization and database building (1). The most
sensitive technique is probably MLVA typing, based on ampli-
fication and detection—often with a capillary sequencer—of
short DNA repeats on different loci (1, 22). These repeats are
often hypervariable and can therefore be very informative with
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regard to strain differentiation. However, the value of small
repeat differences is often not clear (1, 17, 25).
In 2009, a small-scale genotyping study of 3 MLVA loci
including 5 patients, 3 sheep, and 3 lambs suggested a link
between one human Q fever case and a sheep farm. Most of
the genotypes in this study differed only in a single repeat. It
was therefore suggested that the C. burnetii types might rep-
resent microvariants of a hypervirulent strain that has been
introduced in the Dutch animal population (4, 12). However,
thorough genotyping data to provide epidemiological insight
into the Dutch Q fever outbreak are still missing.
A new approach to overcome the problems of currently used
typing techniques is single-nucleotide-polymorphism (SNP)-
based typing. SNP methods are rapid, sensitive, easy to per-
form, and unambiguous in result interpretation (6, 7, 10, 14).
We assumed that SNP genotyping might be well-suited for
genotyping of C. burnetii in an outbreak setting. Therefore, we
set out to develop an SNP genotyping assay for C. burnetii
directly applicable to human and animal samples.
MATERIALS AND METHODS
SNP selection and real-time PCR design. Sequences of approximately 100,000
bp of the complete genomes of C. burnetii strains RSA493 (Nine Mile strain,
GenBank accession no. NC_002971), RSA331 (Henzerling strain, GenBank ac-
cession no. NC_010117), CbuG_Q212 (GenBank accession no. NC_011527),
Cbuk_Q154 (GenBank accession no. NC_011528), and 5J108 111 Dugway (GenBank
accession no. NC_009727) were aligned using Geneouis software (version 4.8.5;
Biomatters Ltd., Auckland, New Zealand). The resulting consensus sequence
was screened for strain-specific SNPs. The Basic Local Alignment Search Tool
(BLAST) from the National Center for Biotechnology Information was used to
confirm whether these SNPs could be of discriminatory value and to determine
the SNP locus.
Using the custom TaqMan assay design tool (Applied Biosystems, Foster City,
CA), we designed real-time PCRs for amplification and detection of the SNPs
(Table 1).
C. burnetii genotyping panel. (i) Reference strains. A reference panel consisted
of DNA from 28 C. burnetii strains previously typed by MLVA (1, 22) and DNA
from commercially obtained strains CbuG_Q212, Priscilla, Henzerling, Luga,
and Q229 (Universite´ de la Me´diterrane´e, Marseille, France). The strains were
isolated from humans, ticks, and ruminants (ovine, caprine, and bovine strains)
in the years from 1937 to 2000 (Table 2). As presented in Table 2, several strains
were included multiple times. The two Nine Mile strains (strains RSA493 and
RSA439, phases I and II, respectively) represent strains from two different
passages (22), the three Priscilla strains are from two different passages (22) and
one was commercially obtained, the two Henzerling strains represent one refer-
ence strain (22) and one strain obtained commercially, and the two Luga strains
have been described previously (1, 22).
(ii) Dutch outbreak-related samples. A total of 40 clinical/outbreak-related
samples were included: 14 of human origin and 26 of animal origin (Table 3). Six
serum samples were obtained from patients (5 males and 1 female) in the early
phase of acute Q fever. After 12 months of follow-up, two of these five patients
had developed chronic Q fever (defined as high IgG antibody titers against C.
burnetii phase I antigen with a positive IS1111 PCR result with a serum or tissue
sample), while two other patients successfully cleared their infections. One pa-
tient still awaits the 12-month serological follow-up. No clinical data from one
patient were available. One semen sample was obtained from a chronic Q fever
patient with an aortic prosthesis who suffered from epididymitis. Seven tissue
samples were derived from patients (5 males and 2 females) diagnosed with
chronic Q fever. Tissue samples 1, 2, 4, 5, and 7 were from an aortic aneurysm.
Tissue sample 3 was from a prosthesis of the aorta ascendens. Tissue sample 6
was derived from an iliac artery aneurysm. The mean age of the 14 patients was
59  21 years. Thirteen of the 14 human clinical materials were derived from
patients living in Noord-Brabant, the Q fever epidemic center, and 1 (serum
sample 6) was from a Dutch outbreak area close to the Belgian-Dutch border.
All human samples were obtained for diagnosis-related purposes. The study was
carried out with the approval of the Board of Directors and the Scientific
Advisory Board of the Jeroen Bosch Hospital.
The veterinary samples included one goat placenta sample, two cow colostrum
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samples, one commercial cow milk sample, one sheep placenta sample, and
samples from 13 dairy farms (9 goat farms and 4 goat/cow farms). From the dairy
farms, 9 bulk goat milk and 4 bulk cow milk samples from tanks and 5 individual
goat milk samples were obtained. In addition, 2 swabs (from a barn fence and
from power cables) from goat farm 13 and a hand swab obtained after a goat
from farm 12 was petted (fur swab) were included. Farms 1, 4, and 9 were located
outside the Q fever epidemic center.
DNA extraction. (i) Human serum. DNA was extracted from 500 l of serum
using a NucliSens EasyMAG extraction system (bioMe´rieux, Boxtel, Nether-
lands). Five hundred microliters of serum was added to 2 ml NucliSens lysis
buffer and incubated for 10 min at room temperature. Magnetic silica particles
were diluted 1:1 (vol/vol) with ultrapure water. One hundred microliters of
diluted magnetic silica particles was added to each lysate. The samples were
further processed according to the manufacturer’s instructions and eluted in 60
l of elution buffer. TE buffer (1 mmol/liter EDTA, 10 mmol/liter Tris-HCl
buffer, pH 8.0) was added to a final volume of 180 l.
(ii) Human tissue and veterinary samples. To efficiently extract DNA, pro-
teinase K digestion was performed prior to DNA extraction. Two hundred fifty
microliters of liquid sample or approximately 50 to 100 mm3 of tissue was
digested with 25 l of proteinase K (20 mg/ml; Roche Diagnostics GmbH,
Mannheim, Germany) and 225 l digestion solution (produced by adding 1 ml of
1 M Tris-HCl buffer, pH 8.0, and 2.5 ml 10% SDS to 44 ml of ultrapure water).
Digestion was performed in a thermoshaker at 55°C and 1,400 rpm overnight.
DNA was extracted as described above.
SNP real-time PCR. SNP amplification assays were used according to the
manufacturer’s instructions. The 25-l PCR mixture contained 20 mmol/liter
Tris-HCl, pH 8.4, 50 mmol/liter KCl, 5 mmol/liter MgCl2 (prepared from 10
PCR buffer [Invitrogen BV, Breda, Netherlands] and 50 mmol/liter MgCl2 so-
lution [Applied Biosystems]), 0.75 U of Ex Taq HS polymerase (TaKaRa Bio,
Otsu, Japan), 0.01% bovine serum albumin (molecular biology grade; Westburg
BV Benelux, Leusden, Netherlands), 200 mol/liter of each deoxynucleoside
triphosphate (Invitrogen BV), 0.5 l of carboxy-X-rhodamine reference dye
(Invitrogen BV), 1.25 l of an SNP primer-probe pool (Applied Biosystems)
containing two primers and two MGB TaqMan probes (5 VIC for allele 1, 5
6-carboxyfluorescein [FAM] for allele 2, and a 3 nonfluorescent quencher
[NFQ]), and 11.25 l of eluted target DNA. An ABI Prism 7500 Fast sequence
detection system (Applied Biosystems) was used for amplification and detection
(10 min at 95°C, 45 cycles of 3 s at 95°C and 30 s at 60°C, and an infinite hold step
at 25°C in Fast 7500 mode). Data analysis was performed using SDS software
(version 1.3.1). Linear amplification plots were analyzed with a baseline from
cycle 6 to cycle 15 for both reporters.
RESULTS
SNP selection and real-time PCR design. SNPs were se-
lected on the basis of both the consensus sequence (data not
shown) generated from 100,000 bp of the 5 known whole-
genome sequences of C. burnetii (RSA493, RSA331,
CbuG_Q212, Cbuk_Q154, and 5J108 111 Dugway) and an in
silico investigation of their discriminatory power using BLAST.
A total of 10 specific real-time PCR SNP genotyping assays
were designed: 7 based on different single-copy genes and 3
based on the multicopy insertion sequence IS1111 (21). The
SNPs and the oligonucleotides designed for the real-time am-
plification and detection are presented in Table 1. In silico, no
additional SNPs were present in the target sequences.
C. burnetii genotyping panel. (i) Reference strains. SNPs
769, 2287, 4439, 4557, 4844, 5423, and 6025 (positions indi-
cated in reference sequence RSA493, GenBank accession no.
AE016828.2) are located within single-copy genes, and the
results are therefore binary in nature. Allelic discrimination of
TABLE 2. Panel of reference strains, SNP-based genotyping results, SNP genotypes, and reference MLVA genotypesa
a Gray and white squares indicate the presence and absence of the allele for the SNPs located within the single-copy genes, respectively (Fig. 1A). Green and light
green squares indicate the presence of the allele for the SNPs located within the multicopy IS1111 element, with dark green squares yielding a different curve than light
green squares. White squares indicate the absence of the allele (Fig. 1B). A, adenine; G, guanine; C, cytosine; T, thymine. The blue squares indicated for SNP 4557
strain CbB10 represent the presence of both alleles. Matching colors in the SNP genotype column represent identical SNP profiles.
b MLVA types indicated by numbers (1) and letters (24) were published elsewhere.
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SNP 2287, a representative of the 7 SNPs located within the
single-copy genes, is depicted in Fig. 1A. As expected, two
groups were clearly distinguishable.
SNPs 7087, 7726, and 7974 are located within multicopy
insertion sequence IS1111 (positions within the first IS1111
encountered, as indicated in the strain RSA493 reference se-
quence, GenBank accession no. AE016828.2), which is distrib-
uted throughout the C. burnetii genome. Because of the genetic
variation in the up to 100 (13) different IS1111 elements within
one strain, in theory more than 2 real-time PCR profiles can be
expected. Two fluorescent profiles were encountered for SNP
7087, 4 for SNP 7726, and 3 for SNP 7974. The representative
allelic discrimination of SNP 7726 is depicted in Fig. 1B. All
fluorescent profiles observed from the 30 strains in the valida-
tion panel and the 24 outbreak samples could be allocated to
one of the depicted profiles. A total of 9 distinct SNP geno-
types were distinguished (Table 2).
The experimental SNP data obtained for strains RSA493,
RSA331, and CbuG_Q212 were in agreement with the expec-
tation based on the sequence information. The SNP profile of
the Nine Mile strains after passage 3 in embryonated hen eggs
(EP3; RSA493, phase I) was identical to the profile of the
strains after passage 165 (EP165; RSA439, phase II). For strain
Priscilla, EP3 and EP50 yielded results identical to those for a
Priscilla strain from another source. Two different batches of
strains Henzerling and Luga from two different sources also
yielded identical results (data not shown). Thus, the fluores-
cent profiles appear to be highly reproducible and provide
reliable SNP profiles. To assess the discriminatory power of the
SNP genotyping test, we included the MLVA types in Table 2.
TABLE 3. Panel of Dutch Q fever outbreak samples, SNP-based genotyping results, and SNP genotypesa
a Gray and white squares indicate the presence and absence of the allele for the SNPs located within the single copy genes, respectively (Fig. 1A). Dark green and
white squares indicate the presence and absence of the allele for the SNPs located within the multicopy IS1111 element, respectively (Fig. 1B). A, adenine; G, guanine;
C, cytosine; T, thymine. Matching colors in the SNP genotype column represent identical SNP profiles.
b t, time (days).
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Among the 28 reference strains representing 14 MLVA types,
9 SNP types were distinguished. The concordance between the
SNP genotyping test and MLVA typing was 93%.
(ii) Dutch outbreak-related samples. We subsequently de-
termined the SNP types of the strains in the Dutch human
clinical and veterinary materials (Table 3). The strains from all
7 human vascular tissue samples, 2 serum samples, and the
semen sample clustered in SNP genotype group 1. The 2 serum
samples were from one patient who had not progressed to
chronic Q fever and from a patient still awaiting analysis of the
12-month sample. The residences of the 10 patients clustering
in SNP genotype group 1 were distributed throughout the
whole outbreak area in Noord-Brabant. SNP genotype group 1
was also present in cow colostrum sample 1; goat placenta;
sheep placenta; bulk goat milk samples from a tank; individual
goat milk samples from farms 5, 6, 8, and 9; a bulk cow milk
sample from farm 10; and the fur swab at farm 12. The majority
of the goat farms with SNP genogroup 1 were located in the
center of the Q fever epidemic. Goat farm 9 was located well
outside this area. From the reference panel, 3 caprine strains
from France and 1 ovine strain from Morocco clustered in SNP
genotype group 1. Three other human serum samples clustered
in SNP genotype group 6. One sample was derived from a
patient who had cleared the infection, while the other 2 sam-
ples were from patients who had progressed to chronic Q fever.
These patients lived within a 3-mile radius of each other. Bulk
goat milk and two swabs from farm 13, located near the resi-
dences of these three patients, contained the same SNP geno-
type. From the reference panel, the goat-derived Priscilla
strain from the United States and two ovine strains from
France clustered in SNP genotype group 6.
Strains from bulk goat milk samples derived from farms 1
and 4, both located outside the epidemic center of the Q fever
outbreak, clustered in SNP genotype group 2. To this SNP
genotype also belonged the strains from bulk cow milk samples
from farms 4, 7, and 10; cow colostrum sample 2; and the
commercial cow milk. Of the reference strains, French caprine
strain CbC1 and all bovine strains from France except CbB10
clustered in SNP genotype group 2. The strain from the bulk
goat milk sample from a tank from farm 2 was the only one of
SNP genotype group 4. Of the reference panel, strain L35
derived from a Slovakian human blood sample clustered in this
group. Serum sample 6 from Belgium was the only sample that
contained SNP genotype 8. A number of tick-derived reference
strains from Slovakia and Russia and human-derived strains
Henzerling from Italy and Florian from Slovakia also displayed
this genotype. None of the Dutch human clinical materials
clustered in SNP genotype group 2 or 4.
DISCUSSION
SNP genotyping of C. burnetii provides informative epide-
miological insight and is particularly suitable for direct typing
of strains from clinical and veterinary materials. Because only
small stretches of target DNA are amplified, the SNP assays
are especially appropriate for use with serum samples in which
fragmented DNA is supposedly present (24). In addition, the
SNP genotyping method has a short turnaround time (approx-
FIG. 1. Representative allelic discrimination plots. (A) SNP 2287 located on a single-copy gene. Blue circle, presence of adenine (white and
gray squares in Tables 2 and 3); red circle, presence of guanine (gray and white squares in Tables 2 and 3). (B) SNP 7726 located on the multicopy
IS1111 element. Blue circle, presence of guanine only (white and green squares in Tables 2 and 3); red circle, presence of cytosine only (green and
white squares in Tables 2 and 3); green circle and single pink dot, presence of both guanine and cytosine (dark green and dark green and light
green and dark green squares in Tables 2 and 3, respectively) in distinct quantities.
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imately 2 h from the time of DNA extraction to a result); can
be performed in any real-time PCR machine, which is standard
equipment in many molecular laboratories; and does not re-
quire expensive DNA sequencing equipment, which is needed
for, e.g., MLVA. Another advantage of the SNP profiling test
is that processing after PCR is not required in real-time PCR
analysis. This substantially reduces the risk of contamination
with PCR products (10).
Employing a panel of 10 carefully selected SNPs, 7 located in
single-copy genes and 3 located in multicopy IS1111, a total of
9 SNP genotypes could be distinguished among 28 C. burnetii
reference strains representing 14 MLVA types. On the basis of
the concordance rate, the discriminatory power of SNP geno-
typing may be somewhat lower than that of MLVA typing.
Nevertheless, the differences observed between many of the
MLVA types which the SNP genotyping could not distinguish
were based on a single repeat difference in all strains except
strain CbC4 (1, 22). Intracellular bacteria, of which C. burnetii
is a recent associate, are known for their genome reduction by
shedding of noncrucial genomic elements (27). Hence, the
question that remains is whether the repeat regions selected
for MLVA genotyping show adequate stability, an issue previ-
ously raised and discussed (1, 17, 25). The same might be true
for the markers chosen for the SNP genotyping method. With
regard to marker stability, however, we analyzed and com-
pared the SNP profiles generated from the DNA derived from
the Priscilla and the Nine Mile strains after EP3 to those
observed after EP50 and EP165, respectively. The SNP profiles
before and after passage proved to be identical. This indicates
that the selected SNPs show sufficient stability to not be influ-
enced by a large number of passages.
Caprine strains CbC2, CbC4, and CbC5 from France and
ovine strain CbO4 from Morocco grouped together in SNP
genotype group 1. Strains CbB1, CbB2, CbB3, CbB4, CbB5,
and CbB7, all of bovine origin, and caprine strain CbC1 were
also isolated in France and clustered in SNP genotype group 2.
Strains L35, CbC7, and CbB10 were designated SNP genotypes
4, 5, and 7, respectively. Strain CbB10 displayed an SNP profile
indicative of a duplication of (part) of the DNA gyrase B
subunit-encoding gene (data not shown). The three Priscilla
strains clustered together, as expected, in SNP genotype 6,
which was shared by ovine strains CbO1 and CbO2, both iso-
lated in France. SNP genotype group 8 consisted of strains
isolated from humans and ticks in Italy, Slovakia, and Russia.
The clustering of strains CbuG_Q212, Q229, and S in SNP
genotype 9 could be supported by a geographical link (Nova
Scotia and the United States) between the strains, and in
addition, all three were isolated in the early 1980s.
SNP genotyping of the Dutch outbreak panel revealed 3
distinct genotypes among human samples and 4 distinct geno-
types among livestock. Thus, multiple C. burnetii strains have
infected humans in the Dutch Q fever outbreak. The human
tissues clustered in SNP genotype 1, together with two human
serum samples, a human semen sample, a cow colostrum sam-
ple, a goat placenta sample, a sheep placenta sample, goat milk
from seven farms, bulk cow milk from one of these farms, and
a fur swab from another farm. It is interesting to note that
some farmers use raw cow colostrum to feed the newborn
goats. Three human serum samples clustered in SNP group 6,
together with several materials from farm 13, the Priscilla
strain, and ovine strains CbO1 and CbO2 from France. Al-
though SNP genotype 6 was detected only in the serum sam-
ples taken during the acute phase of disease, one of these
patients later developed chronic disease. Assuming that this
patient was not reinfected with a second C. burnetii strain, both
SNP genotype 1 and genotype 6 may cause chronic disease in
humans. If the C. burnetii strain from genotype 6 found in the
patient samples shares not only the SNP profile but also the
antibiotic resistance properties of the Priscilla strains, this may
have consequences for the antibiotic regimen used for patients
infected with this strain (28). Almost all the sources of the
samples in which SNP genotype 1 was identified were located
within a surface area of approximately 150 square miles and
could therefore be epidemiologically linked. One goat milk
sample from a farm located outside the outbreak area also
yielded SNP genotype 1. This indicates the further spread of
this C. burnetii strain in the Netherlands. The patients infected
with C. burnetii SNP genotype 6 lived at the edge of the main
outbreak area within a 3-mile radius from each other and the
goat farm with this genotype.
The direct SNP typing of bulk milk samples raises questions
about clonality, since multiple genotypes could theoretically be
present at one farm. At farm 4, two different groups of goats
and the cows displayed one identical SNP genotype. The SNP
profiles from bulk milk samples showed the presence of 1 allele
in the SNPs located on single-copy genes. These findings sug-
gest the presence of a single strain at each farm. At farm 10,
however, 2 SNP genotypes were found. Bulk milk from goats as
well as bulk milk from one group of cows contained SNP
genotype 1, while bulk milk from a distinct group of cows
yielded SNP genotype 2. Apparently, two C. burnetii strains
have infected separate groups of animals on that farm.
Two of the veterinary genotypes have thus far not been
linked to human cases in the Netherlands. Two of the farms
where one of these genotypes was found were located outside
the major outbreak area, in the northwest and center of the
Netherlands, where only a small number of people fell ill.
One human serum sample from the Dutch-Belgian border
area contained SNP genotype 8. This SNP genotype has not
been linked to any animal source thus far.
Strains Priscilla, RSA493, Henzerling, and Luga were ana-
lyzed multiple times. All analyses yielded identical results in-
dicating that the SNP genotyping assay provided good repro-
ducibility. On the basis of these findings, we expect that the
technique is suitable for interlaboratory standardization and
database building. Gel-based techniques have proven to be
more difficult to standardize and are therefore less suitable for
these purposes (1).
With regard to the analysis of weakly positive samples, cau-
tion is advised for the interpretation of the signals. The sensi-
tivity of SNP genotyping was estimated to be about 100 ge-
nome copies per reaction for the SNPs located on single-copy
genes and about 10 genome copies per reaction for the SNPs
located on IS1111. Although the 3 IS1111 SNPs do not provide
the full resolution of the total SNP panel, typing of materials
containing small amounts of DNA with only these SNPs may
provide crucial information regarding the C. burnetii type.
In conclusion, we have developed a novel SNP genotyping
method suitable for direct typing of C. burnetii from a wide
variety of clinical and veterinary samples. With this typing
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method, we have shown that at least five distinct genotypes
(three found in humans and four found in livestock) are pres-
ent in the Dutch outbreak. This implies that environmental
circumstances (such as the high density of farms and people,
dry periods during spring) rather than one highly virulent C.
burnetii strain favored the Dutch Q fever spread. Further re-
search will have to resolve the question of whether all geno-
types present in livestock are able to cause human disease or
whether some strains are more virulent or infectious than
others.
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